Getwell Pharmaceuticals — Etoposide Exporter Profile
Indian Pharmaceutical Exporter · #8 for Etoposide · $136.2K export value · DGFT Verified
Getwell Pharmaceuticals is the #8 Indian exporter of Etoposide with $136.2K in export value and 35 verified shipments. Getwell Pharmaceuticals holds a 1.3% market share in Etoposide exports across 9 countries. The company exports 7 pharmaceutical products worth $1.5M across 3 therapeutic categories.
Getwell Pharmaceuticals — Etoposide Export Profile: Buyers & Destinations
Where Does Getwell Pharmaceuticals Export Etoposide?
| Country | Value | Shipments | Share |
|---|---|---|---|
| PHILIPPINES | $115.6K | 14 | 84.9% |
| NEPAL | $9.4K | 6 | 6.9% |
| DOMINICAN REPUBLIC | $4.4K | 2 | 3.2% |
| PANAMA | $2.2K | 1 | 1.6% |
| JAMAICA | $2.2K | 4 | 1.6% |
| KENYA | $1.1K | 4 | 0.8% |
| TAJIKISTAN | $999 | 1 | 0.7% |
| MAURITIUS | $208 | 2 | 0.2% |
| MADAGASCAR | $204 | 1 | 0.1% |
Getwell Pharmaceuticals exports Etoposide to 9 countries. The largest destination is PHILIPPINES accounting for 84.9% of Getwell Pharmaceuticals's Etoposide shipments, followed by NEPAL (6.9%) and DOMINICAN REPUBLIC (3.2%). These destinations reflect Getwell Pharmaceuticals's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Etoposide from Getwell Pharmaceuticals?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| AGB PHARMACEUTICAL TRADING AND | PHILIPPINES | $71.3K | 7 |
| AGB PHARMACEUTICAL TRADING AND CONS | PHILIPPINES | $35.2K | 6 |
| AGB PHARMACEUTICAL TRADING AND CONSULTANCY CORPORATION | PHILIPPINES | $9.1K | 1 |
| VISION CARE INTERNATIONAL PVT. LTD. | NEPAL | $7.1K | 5 |
| CAPIS MEDICAL SA | DOMINICAN REPUBLIC | $4.4K | 2 |
| VISION CARE INTERNATIONAL PVT LTD | NEPAL | $2.3K | 1 |
| CAPIS MEDICAL S A | PANAMA | $2.2K | 1 |
| RECHARGED DISTRIBUTORS LIMITED | JAMAICA | $2.2K | 4 |
| LLC C NOZI SBO | TAJIKISTAN | $999 | 1 |
| M/S NAIROBI ENTERPRISES LTD. | KENYA | $716 | 3 |
Getwell Pharmaceuticals supplies Etoposide to 14 buyers globally. The largest buyer is AGB PHARMACEUTICAL TRADING AND (PHILIPPINES), followed by AGB PHARMACEUTICAL TRADING AND CONS (PHILIPPINES) and AGB PHARMACEUTICAL TRADING AND CONSULTANCY CORPORATION (PHILIPPINES). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Etoposide Export Value and How Much Does Getwell Pharmaceuticals Contribute?
India exported $9.5M worth of Etoposide through 2,129 shipments from 237 suppliers to 122 countries, serving 598 buyers globally. Getwell Pharmaceuticals contributes $136.2K to this total, accounting for 1.3% of India's Etoposide exports. Getwell Pharmaceuticals ships Etoposide to 9 countries through 14 buyers.
What Is the Average Shipment Value for Getwell Pharmaceuticals's Etoposide Exports?
Getwell Pharmaceuticals's average Etoposide shipment value is $3.9K per consignment, based on 35 shipments totaling $136.2K. The largest destination is PHILIPPINES (84.9% of Getwell Pharmaceuticals's Etoposide exports).
How Does Getwell Pharmaceuticals Compare to Other Indian Etoposide Exporters?
Getwell Pharmaceuticals ranks #8 among 237 Indian Etoposide exporters with a 1.3% market share. The top 3 exporters are INTAS PHARMACEUTICALS LIMITED ($4.8M), FRESENIUS KABI ONCOLOGY LIMITED ($1.9M), VENUS REMEDIES LIMITED ($988.8K). Getwell Pharmaceuticals processed 35 shipments to 9 destination countries.
What Etoposide Formulations Does Getwell Pharmaceuticals Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| ETOPA 100MG/5ML (ETOPOSIDE INJECTION USP | $61.0K | 18 |
| ETOPA 100MG/5ML (ETOPOSIDE INJECTION USP)BATCH NO. 4GET01, MFG.DT. 02/2024, EXP.DT. 01/2026 | $15.8K | 1 |
| ETOPOJECT 100MG/5ML (ETOPOSIDE INJECTION USP)BATCH NO. 4GET02, MFG.DT. 02/2024, EXP.DT. 01/2026 | $10.3K | 1 |
| ETOPOJECT 100MG/5ML ETOPOSIDE INJECTIONUSP BATCH NO. 3GET06 MANUFACTURING .DT. 07/2023EXP.DT. 06/2025 | $9.1K | 1 |
| ETOPOJECT 100MG/5ML (ETOPOSIDE INJECTIONUSP) BATCH NO. 3GET08, MFG.DT. 12/2023,EXP.DT. 11/2025NOS | $8.8K | 3 |
| ETOPA 100MG/5ML (ETOPOSIDE INJECTION USP) BATCH NO. 3GET07, MFG.DT. 11/2023,EXP.DT. 10/2025NOS | $8.8K | 1 |
| ETOPOJECT 100MG 5ML ETOPOSIDE INJECTION USP BATCH NO 3GET02 MFG DT 02 2023 EXP DT 01 2025 | $8.7K | 1 |
| ETOPOSIDE INJECTION USP 100MG/5MLBATCHNO. 3GET05, MANUFACTURING .DT. 05/2023, EXP.DT. 04/2025 | $6.6K | 3 |
| ETOPA 100MG/5ML (ETOPOSIDE INJECTION USP)BATCH NO. 3GET06, MFG.DT. 07/2023, EXP.DT. 06/2025 | $2.4K | 1 |
| ETOPA 100MG/5ML ETOPOSIDE INJECTION USP BATCH NO. 3GET05, MANUFACTURING .DT. 05/2023, EXP.DT. 04/2025 | $2.3K | 1 |
Getwell Pharmaceuticals exports 14 distinct Etoposide formulations including tablets, capsules, syrups, and combination drugs. The top formulation is ETOPA 100MG/5ML (ETOPOSIDE INJECTION USP with 18 shipments worth $61.0K.
How Does Getwell Pharmaceuticals Compare to Nearest Etoposide Exporters?
Exporters ranked immediately above and below #8 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 7 | INTAS PHARMACEUTICALS LTD | $294.6K | 16 | 6 | $18.4K |
| 6 | MEDORBIS TRADE LLP | $200.0K | 4 | 2 | $50.0K |
| 8 | GETWELL PHARMACEUTICALS ★ | $136.2K | 35 | 9 | $3.9K |
| 9 | NV REMEDIES PRIVATE LIMITED | $132.6K | 5 | 3 | $26.5K |
| 10 | KHANDELWAL LABORATORIES PRIVATE LIMITED | $98.1K | 14 | 5 | $7.0K |
Getwell Pharmaceuticals ranks #8 among 237 Indian Etoposide exporters. Average shipment value of $3.9K compared to the market average of $40.3K. The closest competitors by value are INTAS PHARMACEUTICALS LTD and MEDORBIS TRADE LLP.
Which Indian Ports Ship Etoposide Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR | 357 | 16.8% |
| SAHAR AIR CARGO ACC (INBOM4) | 333 | 15.6% |
| DELHI AIR | 258 | 12.1% |
| DELHI AIR CARGO ACC (INDEL4) | 244 | 11.5% |
| AHEMDABAD AIR ACC (INAMD4) | 141 | 6.6% |
| AHEMDABAD AIR | 135 | 6.3% |
| MUNDRA SEA (INMUN1) | 129 | 6.1% |
| Bombay Air | 96 | 4.5% |
What Other Oncology Products Does Getwell Pharmaceuticals Export?
Getwell Pharmaceuticals also exports these oncology products. Each links to the detailed product page.
About Getwell Pharmaceuticals
Getwell Pharmaceuticals exports 7 products worth $1.5M. Beyond Etoposide, top products include Protein, Doxorubicin, Ifosfamide, Cyclophosphamide, Fluorouracil. View the complete Getwell Pharmaceuticals profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Etoposide — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Etoposide shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Getwell Pharmaceuticals matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 35 individual customs records matching Getwell Pharmaceuticals exporting Etoposide, covering 14 formulations to 9 countries via 14 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 122+ countries, 598+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Etoposide Export Data from Getwell Pharmaceuticals
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Getwell Pharmaceuticals's Etoposide exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Getwell Pharmaceuticals
Full Company Profile →
7 products · $1.5M total trade · 3 categories
Etoposide Stats
Company Overview
Top Products by Getwell Pharmaceuticals
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Getwell Pharmaceuticals.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Etoposide. For current shipment-level data, contact TransData Nexus.